The Chemours Company (NYSE:CC) Q2 2022 Earnings Conference Call July 29, 2022 8:30 AM ET Company Participants Mark Newman - President, Chief Executive Officer Sameer Ralhan - Senior Vice President, Chief Financial Officer Jonathan Lock - Senior Vice President, Chief Development Officer Conference Call Participants Arun Viswanathan - RBC Capital Markets Ross Huffman - Bank of America John McNulty - BMO Capital Markets Mike Leithead - Barclays Josh Spector - UBS Vincent Andrews - Morgan Stanley Kevin Estok - ...

| --- | --- | --- | --- | --- | |------------------------------------------------------|-------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | Chemours 2Q 2022 Earnings Presentation July 28, 2022 | | | | | | | | | | | Safe Harbor Statement and Other Matters This presentation contains forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which involve risks and uncertainties. Forward-look ...

| --- | --- | --- | --- | --- | |----------------------------------------|-------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | Chemours 1Q 2022 Earnings Presentation | | | | | | May 2, 2022 | | | | | Safe Harbor Statement and Other Matters 2 This presentation contains forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which involve risks and uncertainties. Forward-looking statements ...

Call Start: 08:30 January 1, 0000 9:16 AM ET The Chemours Company (NYSE:CC) Q1 2022 Earnings Conference Call May 3, 2022, 8:30 AM ET Company Participants Mark Newman – President, Chief Executive Officer Sameer Ralhan – Senior Vice President, Chief Financial Officer Jonathan Lock – Senior Vice President, Chief Development Officer Conference Call Participants John McNulty – BMO Capital Markets Arun Viswanathan – RBC Capital Markets James Cannon – UBS Michael Leithead – Barclays Hassan Ahmed – Alembic Global A ...

Part I Financial Information [Interim Consolidated Financial Statements](index=3&type=section&id=Item%201.%20Interim%20Consolidated%20Financial%20Statements) The company presents its unaudited interim consolidated financial statements for the three months ended March 31, 2022 Q1 2022 Consolidated Statement of Operations Highlights | Metric | Three Months Ended March 31, 2022 (in millions) | Three Months Ended March 31, 2021 (in millions) | YoY Change | | :--- | :--- | :--- | :--- | | **Net Sales** | $1,764 | $1,436 | +22.8% | | **Gross Profit** | $486 | $297 | +63.6% | | **Income before Income Taxes** | $280 | $101 | +177.2% | | **Net Income** | $234 | $96 | +143.8% | | **Diluted EPS** | $1.43 | $0.57 | +150.9% | [Notes to the Interim Consolidated Financial Statements](index=8&type=section&id=Notes%20to%20the%20Interim%20Consolidated%20Financial%20Statements) Detailed notes disclose accounting policies, segment performance, debt structure, and significant litigation and environmental liabilities - The company operates through three reportable segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials[26](index=26&type=chunk) - Total debt principal stood at **$3.75 billion** as of March 31, 2022, a slight decrease from **$3.78 billion** at year-end 2021[81](index=81&type=chunk) - During Q1 2022, the company repurchased **4.85 million shares for $146 million** under its share repurchase program[233](index=233&type=chunk) Net Sales by Segment (Q1 2022 vs Q1 2021) | Segment | Q1 2022 Net Sales (in millions) | Q1 2021 Net Sales (in millions) | YoY Change | | :--- | :--- | :--- | :--- | | Titanium Technologies | $928 | $723 | +28.4% | | Thermal & Specialized Solutions | $425 | $304 | +39.8% | | Advanced Performance Materials | $385 | $333 | +15.6% | | Other Segment | $26 | $76 | -65.8% | [Commitments and Contingent Liabilities](index=19&type=section&id=Note%2016.%20Commitments%20and%20Contingent%20Liabilities) This note details significant legal and environmental contingencies, including a **$4 billion** cost-sharing MOU for legacy PFAS liabilities - In January 2021, Chemours entered a binding MOU with DuPont and Corteva to share potential future legacy PFAS liabilities up to an aggregate of **$4 billion**[106](index=106&type=chunk)[107](index=107&type=chunk) - The company is named in approximately **2,400 matters** related to Aqueous Film Forming Foam (AFFF) consolidated into a multi-district litigation[135](index=135&type=chunk) - For the Fayetteville site, the company has accrued **$286 million** for on-site remediation and **$80 million** for off-site remediation[189](index=189&type=chunk)[420](index=420&type=chunk) Environmental Remediation Liabilities (as of March 31, 2022) | Site | Liability (in millions) | | :--- | :--- | | Fayetteville Works, NC | $366 | | Pompton Lakes, NJ | $41 | | Chambers Works, NJ | $29 | | USS Lead, IN | $19 | | All other sites | $111 | | **Total** | **$566** | [Management's Discussion and Analysis of Financial Condition and Results of Operations (MD&A)](index=45&type=section&id=Item%202.%20Management's%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) Management discusses Q1 2022 performance, highlighting a **23%** net sales increase to **$1.8 billion** driven by strong pricing and volume - The company announced the suspension of its business with Russian entities in March 2022 in response to the Russia-Ukraine conflict[293](index=293&type=chunk) - The 2022 outlook expects capital expenditures to be approximately **$400 million**[343](index=343&type=chunk) Drivers of Net Sales Change (Q1 2022 vs Q1 2021) | Driver | Percentage Change | | :--- | :--- | | Price | +25% | | Volume | +4% | | Currency | -2% | | Portfolio | -4% | | **Total Change** | **+23%** | [Segment Reviews](index=49&type=section&id=Segment%20Reviews) All primary segments reported strong year-over-year growth in net sales and Adjusted EBITDA, driven by robust pricing and demand Segment Adjusted EBITDA (Q1 2022 vs Q1 2021) | Segment | Q1 2022 Adjusted EBITDA (in millions) | Q1 2021 Adjusted EBITDA (in millions) | YoY Change | | :--- | :--- | :--- | :--- | | Titanium Technologies | $206 | $166 | +24.1% | | Thermal & Specialized Solutions | $174 | $90 | +93.3% | | Advanced Performance Materials | $88 | $58 | +51.7% | [Liquidity and Capital Resources](index=53&type=section&id=Liquidity%20and%20Capital%20Resources) The company maintained a strong liquidity position with **$1.1 billion** in cash, while managing significant future outlays for debt and environmental costs - As of March 31, 2022, the company had total cash and cash equivalents of **$1.1 billion**[346](index=346&type=chunk) - A PFAS escrow payment of **$100 million** is required on or before September 30, 2022, as per the MOU with DuPont and Corteva[350](index=350&type=chunk) Cash Flow Summary (Q1 2022 vs Q1 2021) | Cash Flow Activity | Q1 2022 (in millions) | Q1 2021 (in millions) | | :--- | :--- | :--- | | Operating Activities | $2 | $39 | | Investing Activities | $(110) | $(77) | | Financing Activities | $(189) | $(42) | [Environmental Matters](index=60&type=section&id=Environmental%20Matters) The company details its environmental stewardship goals and significant remediation liabilities, totaling **$566 million**, with a focus on the Fayetteville site - The company has a Corporate Responsibility Commitment goal to reduce absolute Scope 1 and Scope 2 greenhouse gas emissions by **60% by 2030** and achieve net zero by 2050[435](index=435&type=chunk) - Total environmental remediation liabilities were **$566 million** at March 31, 2022, with a potential additional liability up to approximately **$660 million**[388](index=388&type=chunk)[389](index=389&type=chunk) - In Europe, an initiative to restrict a broad range of PFAS substances is underway, with potential restrictions entering force in 2025[447](index=447&type=chunk) [Quantitative and Qualitative Disclosures About Market Risk](index=73&type=section&id=Item%203.%20Quantitative%20and%20Qualitative%20Disclosures%20About%20Market%20Risk) The company utilizes derivative financial instruments to mitigate market risks from foreign currency, interest rates, and commodity prices - The company uses foreign currency forward contracts to hedge against volatility in remeasuring non-functional currency assets and liabilities[472](index=472&type=chunk) - Interest rate swaps are used to mitigate volatility in cash payments for interest on its U.S. dollar-denominated senior secured term loan facility[475](index=475&type=chunk) - Euro-denominated debt is designated as a hedge of the company's net investment in certain European subsidiaries to reduce currency fluctuation volatility[474](index=474&type=chunk) [Controls and Procedures](index=75&type=section&id=Item%204.%20Controls%20and%20Procedures) Management concluded that the company's disclosure controls and procedures were effective as of March 31, 2022 - The CEO and CFO concluded that the company's disclosure controls and procedures were effective as of the end of the period[480](index=480&type=chunk) - There were no changes in internal control over financial reporting during the quarter that have materially affected, or are reasonably likely to materially affect, internal controls[481](index=481&type=chunk) Part II Other Information [Legal Proceedings](index=76&type=section&id=Item%201.%20Legal%20Proceedings) This section references ongoing legal proceedings related to PFOA, PFAS, and environmental issues at key facilities - The company is subject to numerous legal proceedings related to product liability, environmental, and other matters, with significant focus on PFOA and PFAS litigation[484](index=484&type=chunk)[485](index=485&type=chunk) - An alleged criminal offense related to the Netherlands' Environmental Management Act regarding pre-spin use of PFOA is under investigation[490](index=490&type=chunk) [Risk Factors](index=78&type=section&id=Item%201A.%20Risk%20Factors) No material changes to the risk factors disclosed in the 2021 Annual Report on Form 10-K have been reported - No material changes to risk factors from the 2021 Form 10-K were reported[494](index=494&type=chunk) [Unregistered Sales of Equity Securities and Use of Proceeds](index=78&type=section&id=Item%202.%20Unregistered%20Sales%20of%20Equity%20Securities%20and%20Use%20of%20Proceeds) The company details its Q1 2022 share repurchase activity, totaling **$146 million** under its authorized program Share Repurchase Activity (Q1 2022) | Metric | Value | | :--- | :--- | | Total Shares Purchased | 4,851,966 | | Average Price Paid per Share | $30.06 | | Total Amount for Shares Purchased | $146 million | | Remaining Authorization | $105 million |

The Chemours Company (NYSE:CC) Q4 2021 Earnings Conference Call February 11, 2022 8:30 AM ET Company Participants Mark Newman – President and Chief Executive Officer Sameer Ralhan – Senior Vice President and Chief Financial Officer Jonathan Lock – Senior Vice President and Chief Development Officer Conference Call Participants John Silverstein – Wolfe Research John McNulty – BMO Emily Chen – Goldman Sachs Arun Viswanathan – RBC Capital Markets Duffy Fischer – Barclays Vincent Andrews – Morgan Stanley Josh S ...

The Chemours Company Fourth Quarter & Full Year 2021 Earnings Presentation February 11, 2022 Safe Harbor Statement and Other Matters This presentation contains forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which involve risks and uncertainties. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to a hi ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-36794 The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 46-4845564 (State or other Jurisdiction of Incorporation or Organization) (I.R.S. Emplo ...

Financial Data and Key Metrics Changes - Q3 2021 net sales reached $1.7 billion, a 36% increase year-over-year and a 2% increase sequentially [15] - Adjusted EBITDA increased by $162 million to $372 million, with adjusted EBITDA margins rising to 22% from 17% in the prior year [17][18] - Free cash flow for the quarter was $244 million, reflecting a strong commitment to improving earnings quality [18] Business Line Data and Key Metrics Changes - Titanium Technologies segment net sales rose 48% to $908 million, with volumes increasing 33% year-over-year [29] - Thermal & Specialized Solutions segment net sales increased by 9% year-over-year to $318 million, with pricing contributing a 7% tailwind [35] - Advanced Performance Materials segment net sales improved 48% year-over-year to $356 million, driven by 38% volume growth [39] Market Data and Key Metrics Changes - Strong demand for Titanium segment was noted across all regions, with production levels among the highest in history [27] - The automotive OEM sector faced challenges due to semiconductor supply chain constraints, impacting demand in the Thermal & Specialized Solutions segment [34][37] - The Chemical Solutions segment saw net sales of $98 million, an 11% increase year-over-year, driven by robust demand in sodium cyanide and glycolic acid products [42] Company Strategy and Development Direction - The company is focused on sustainable growth and returning cash to shareholders while reducing gross leverage [10] - The AIM Act's implementation is expected to accelerate the adoption of low global warming solutions like Opteon products [13] - The company is enhancing its credit profile and capital allocation strategy, targeting a gross debt reduction to $3.5 billion [24][25] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the ability to drive sustained growth in earnings across all businesses, despite challenges in ore availability and semiconductor supply [44][85] - The company anticipates a high single-digit sequential volume decline for the Titanium Technologies segment in Q4 due to labor disruptions [31] - Management highlighted the importance of maintaining strong relationships with customers and adapting to market conditions [28][80] Other Important Information - The company plans to maintain its quarterly dividend at $0.25 per share, unchanged from the prior quarter [18] - The previously announced sale of a mining solutions business for $520 million is on track to close in Q4 2021 [42] Q&A Session Summary Question: Pricing dynamics in Titanium Technologies - Management noted that pricing activity was driven by a combination of distribution, flex, and contractual customers, with high spot prices reflecting current market conditions [46][47] Question: Supply issues related to ore - Management indicated that major force majeures in the mining space have impacted ore availability, but they expect resolution by mid-2022 [48][49] Question: Pricing in Thermal & Specialized Solutions - Management confirmed that strong pricing was achieved through proactive actions to offset rising raw material costs, despite volume challenges in the automotive sector [50][51] Question: Raw material sourcing and chlorine supply - Management emphasized a strong procurement strategy, ensuring a diversified supply of chlorine and managing energy inflation effectively [52][54] Question: Cash flow and shareholder returns - Management reiterated a commitment to returning the majority of free cash flow to shareholders through dividends and share buybacks, with an acceleration in buyback activity noted in Q3 [57][58] Question: Future growth expectations - Management expressed optimism for growth in EBITDA across all segments, while acknowledging potential constraints in Titanium Technologies due to ore availability [84][85]

The Chemours Company Third Quarter 2021 Earnings Presentation November 5, 2021 Safe Harbor Statement and Other Matters 2 This presentation contains forward-looking statements, within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, which involve risks and uncertainties. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to a historical or current f ...